Cited by 327Health Systems, Economic Evaluations, Quality of LifeParkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

The DOI matches its Crossref record; 34 of the 37 references it cites were found in a registry or an index.

The EQ-5D---a generic quality of life measure---is a useful instrument to measure quality of life in patients with Parkinson's disease

Open access

Schrag, A.·2000·Journal of Neurology, Neurosurgery & Psychiatry

DOI 10.1136/jnnp.69.1.67PMC PMC1737007

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: To test the feasibility and validity of the EQ-5D (a widely used generic (disease non-specific) quality of life (QoL) instrument which allows comparisons between different patient groups and the general population) to assess QoL in patients with Parkinson's disease. METHODS: All 124 patients with Parkinson's disease seen in a community based study on the prevalence of parkinsonism were asked to complete a QoL battery comprising the EQ-5D, the medical outcome study short form (SF-36), the PDQ-39, a disease specific instrument to assess QoL in PD, and the Beck depression inventory. A structured questionnaire interview and a complete neurological examination including the Hoehn and Yahr stage of illness scale, the Schwab and England disability scale, the motor section of the unified Parkinson's disease rating scale (UPDRS), and the mini mental state examination (MMSE) were performed on the same day. RESULTS: The response rate was 78% and the completion rate of the EQ-5D among responders was 96%. The EQ-5D summary index correlated strongly with the PDQ-39 (r=-0.75, p<0.0001) as well as the physical score of the SF-36 (r=0.61, p<0.0001). There was a significant correlation of the EQ-5D summary index with disease severity, as measured by the Hoehn and Yahr stage of illness, the Schwab and England disability scale, the motor section of the UPDRS, and the depression score. The EQ-5D summary index also distinguished between patients with and without depression, falls, postural instability, cognitive impairment hallucinations, and those with deterioration of health over the previous year. CONCLUSION: The EQ-5D is a feasible and valid instrument to measure QoL in Parkinson's disease and reflects the severity and complications of the disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/jnnp.69.1.67

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
Untitled work
(1992) · PubMed · Cited by 33,716
[Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients].
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,852
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,007
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Selective Cortical Undercutting As a Means of Modifying and Studying Frontal Lobe Function in Man
Scoville, W. B. (1949) · Journal of neurosurgery · doi:10.3171/jns.1949.6.1.0065 · Cited by 7,374

Flagged first, then by citations

Show all 37 references

3 of the 37 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

on July 16, 2023 by guest. Protected by copyright. http://jnnp.bmj.com/ J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.69.1.67 on 1 July 2000. Downloaded from
Schwab RS, England AC. Projection technique for evaluat- ing surgery in Parkinson's disease. In: Gillingham FJ, Don- aldson IML, eds. Third Symposium on Parkinson's disease. Edinburgh: Livingstone, 1969:152-7.

Sorted by citations

Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease
Goetz, C. G., Poewe, W. H., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C. E., Giladi, N., Holloway, R. G., Moore, C. G., Wenning, G. K., et al. (2004) · Movement Disorders · doi:10.1002/mds.20213 · Cited by 2,360
Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?
Karimi, M., & Brazier, J. (2016) · PharmacoEconomics · doi:10.1007/s40273-016-0389-9 · Cited by 1,646
The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease
Martínez‐Martín, P., Rodríguez‐Blázquez, C., Kurtis, M. M., Chaudhuri, К. R., & on Behalf of the NMSS Validation Group (2011) · Movement Disorders · doi:10.1002/mds.23462 · Cited by 1,043
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
Olanow, C. W., Kieburtz, K., Odin, P., Espay, A. J., Standaert, D. G., Fernandez, H. H., Vanagunas, A., Othman, A. A., Widnell, K. L., Robieson, W. Z., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70293-x · Cited by 716
Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestations
Jankovic, J. J. (2005) · Movement Disorders · doi:10.1002/mds.20458 · Cited by 549
Impact of the motor complications of Parkinson's disease on the quality of life
Chapuis, S., Ouchchane, L., Metz, O., Gerbaud, L., & Durif, F. (2004) · Movement Disorders · doi:10.1002/mds.20279 · Cited by 534
El EuroQol-5D: una alternativa sencilla para la medición de la calidad de vida relacionada con la salud en atención primaria
Herdman, M., Badia, X. C., & Berra, S. (2001) · Atención Primaria · doi:10.1016/s0212-6567(01)70406-4 · Cited by 487
Quality of life in Parkinson's disease: the relative importance of the symptoms
Rahman, S., Griffin, H. J., Quinn, N. P., & Jahanshahi, M. (2008) · Movement Disorders · doi:10.1002/mds.21667 · Cited by 532
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial.
Gray, R., Ives, N., Rick, C., Patel, S., Gray, A., Jenkinson, C., McIntosh, E., Wheatley, K., Williams, A., & Clarke, C. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60683-8 · Cited by 360
Randomized Delayed-Start Trial of Levodopa in Parkinson’s Disease
Verschuur, C. V. M., Suwijn, S. R., Boel, J. A., Post, B., Bloem, B. R., van Hilten, J. J., van Laar, T., Tissingh, G., Munts, A. G., Deuschl, G., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1809983 · Cited by 353
Health‐related quality‐of‐life scales in Parkinson's disease: Critique and recommendations
Martínez‐Martín, P., Jeukens‐Visser, M., Lyons, K. E., Rodríguez‐Blázquez, C., Selai, C. E., Siderowf, A. D., Welsh, M. D., Poewe, W. H., Rascol, O., Sampaio, C., et al. (2011) · Movement Disorders · doi:10.1002/mds.23834 · Cited by 314
Self-citation
Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments
Marinus, J. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.2.241 · Cited by 291
Young‐ versus older‐onset Parkinson's disease: Impact of disease and psychosocial consequences
Schrag, A. E., Hovris, A., Morley, D., Quinn, N. P., & Jahanshahi, M. (2003) · Movement Disorders · doi:10.1002/mds.10527 · Cited by 296
Self-citation
Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial
Cella, D. F., Grünwald, V., Escudier, B. J., Hammers, H. J., George, S., Nathan, P., Grimm, M., Rini, B. I., Doan, J. F., Ivanescu, C., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30778-2 · Cited by 253
Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: Final 12‐month, open‐label results
Fernandez, H. H., Standaert, D. G., Hauser, R. A., Lang, A. E., Fung, V. S. C., Klostermann, F., Lew, M., Odin, P., Steiger, M. J., Yakupov, E. Z., et al. (2014) · Movement Disorders · doi:10.1002/mds.26123 · Cited by 253
Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial
Sumukadas, D., Witham, M. D., Struthers, A. D., & McMurdo, M. E. T. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.061339 · Cited by 246
Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study
Ehrt, U., Broich, K., Larsen, J. P., Ballard, C., & Aarsland, D. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.186239 · Cited by 254
The Gilles de la Tourette Syndrome–Quality of Life Scale (GTS-QOL)
Cavanna, A. E., Schrag, A. E., Morley, D., Orth, M., Robertson, M. M., Joyce, E. M., Critchley, H., & Selai, C. E. (2008) · Neurology · doi:10.1212/01.wnl.0000327890.02893.61 · Cited by 235
Self-citation
Use of the QOL-AD for measuring quality of life in people with severe dementia—the LASER-AD study
Hoe, J., Katona, C., Roch, B., & Livingston, G. (2005) · Age and Ageing · doi:10.1093/ageing/afi030 · Cited by 230
Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial
Cella, D. F., Grünwald, V., Nathan, P., Doan, J. F., Dastani, H. B., Taylor, F. C., Bennett, B., DeRosa, M., Berry, S. M., Broglio, K. R., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30125-5 · Cited by 219
Initiation of pharmacological therapy in Parkinson's disease: when, why, and how
de Bie, R. M. A., Clarke, C. E., Espay, A. J., Fox, S. H., & Lang, A. E. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30036-3 · Cited by 200
Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?
Du, X., & Pang, T. Y. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00032 · Cited by 221
Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
Parkinson Study Group CALM Cohort Investigators (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.32 · Cited by 213
A Review of the Health-Related Quality of Life and Economic Impact of Parkinson??s Disease
Dowding, C. H., Shenton, C. L., & Salek, S. (2006) · Drugs & Aging · doi:10.2165/00002512-200623090-00001 · Cited by 207
Effects of dyskinesias in Parkinson's disease on quality of life and health‐related costs: a prospective European study
Péchevis, M., Clarke, C. E., Vieregge, P., Khoshnood, B., Deschaseaux, C., Berdeaux, G., Ziegler, M., & on behalf of the Trial Study Group (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01096.x · Cited by 197
Predictors and course of health‐related quality of life in Parkinson's disease
Forsaa, E. B., Larsen, J. P., Wentzel‐Larsen, T., Herlofson, K., & Alves, G. W. (2008) · Movement Disorders · doi:10.1002/mds.22121 · Cited by 186
Increasing access to specialty care: A pilot, randomized controlled trial of telemedicine for Parkinson's disease
Dorsey, E. R., Deuel, L. M., Voss, T., Finnigan, K. S., George, B. P., Eason, S., Miller, D. W., Reminick, J. I., Appler, A., Polanowicz, J., et al. (2010) · Movement Disorders · doi:10.1002/mds.23145 · Cited by 188
A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis
Grosset, D. G., Taurah, L., Burn, D. J., MacMahon, D. G., Forbes, A. B., Turner, K., Bowron, A., Walker, R. W., Findley, L. J. J., Föster, O., et al. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.098327 · Cited by 181
Sweating dysfunction in Parkinson's disease
Swinn, L., Schrag, A. E., Viswanathan, R., Bloem, B. R., Lees, A. J., & Quinn, N. P. (2003) · Movement Disorders · doi:10.1002/mds.10586 · Cited by 174
Self-citation
Health-related quality of life in patients with narcolepsy
Dodel, R. C., Peter, H., Spottke, A. E., Noelker, C., Althaus, A., Siebert, U., Walbert, T., Kesper, K., Becker, H. F., & Mayer, G. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2006.10.010 · Cited by 169
Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries
Hechtner, M., VOGT, T. M., Zöllner, Y. F., Schröder, S., Sauer, J. B., Binder, H., Singer, S., & Mikolajczyk, R. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.06.001 · Cited by 164
Apathy and Depression in Parkinson Disease
Oguru, M., Tachibana, H., Toda, K., Okuda, B., & Oka, N. (2009) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988709351834 · Cited by 151
Factors affecting the quality of life of patients with idiopathic Parkinson's disease-a cross-sectional study in an outpatient clinic attendees
Sławek, J. W., Derejko, M., & Lass, P. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.04.006 · Cited by 145
Levodopa-Associated Dyskinesia Risk Among Parkinson Disease Patients in Olmsted County, Minnesota, 1976-1990
van Gerpen, J. A., Kumar, N., Bower, J. H., Weigand, S. D., & Ahlskog, J. E. (2006) · Archives of Neurology · doi:10.1001/archneur.63.2.205 · Cited by 142
The SF-36 in multiple sclerosis: why basic assumptions must be tested
Hobart, J. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.3.363 · Cited by 136
The benefits of a standardized patient education program for patients with Parkinson's disease and their caregivers
A’Campo, L. E. I., Wekking, E. M., Kamminga, N. G. A., le Cessie, S., & Roos, R. A. C. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.07.009 · Cited by 135
A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need
Chaudhuri, К. R., Rojo, J. M., Schapira, A. H. V., Brooks, D. J., Stocchi, F., Odin, P., Antonini, A., Brown, R. G., & Martínez‐Martín, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057221 · Cited by 122
Anxiety and depression: Main determinants of health-related quality of life in Brazilian patients with Parkinson's disease
Carod-Artal, F. J., Ziomkowski, S., Mesquita, H., & Martínez‐Martín, P. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.06.011 · Cited by 122
Health‐related quality of life in multiple system atrophy
Schrag, A. E., Geser, F., Stampfer‐Kountchev, M., Seppi, K., Sawires, M., Köllensperger, M., Scherfler, C., Quinn, N. P., Pellecchia, M. T., Barone, P., et al. (2006) · Movement Disorders · doi:10.1002/mds.20808 · Cited by 120
Self-citation
Anxiety and depression in patients with Parkinson's disease.
Yamanishi, T., Tachibana, H., Oguru, M., Matsui, K., Toda, K., Okuda, B., & Oka, N. (2013) · Internal medicine · doi:10.2169/internalmedicine.52.8617 · Cited by 123
Health-Related Quality of Life and Healthcare Utilisation in Patients with Parkinson??s Disease
Dodel, R. C., Berger, K., & Oertel, W. H. (2001) · PharmacoEconomics · doi:10.2165/00019053-200119100-00004 · Cited by 117
A comprehensive model of health-related quality of life in Parkinson’s disease
Jeukens‐Visser, M., van Rooden, S. M., Verbaan, D., Marinus, J., Stiggelbout, A. M., & van Hilten, J. J. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0994-4 · Cited by 117
Health‐related quality of life in patients with Gilles de la Tourette's syndrome
Müller‐Vahl, K., Dodel, I., Müller, N., Münchau, A. M., Reese, J. P., Balzer‐Geldsetzer, M., Dodel, R. C., & Oertel, W. H. (2010) · Movement Disorders · doi:10.1002/mds.22900 · Cited by 114
Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: the ANIMO study
Benito‐León, J., Cubo, E., Coronell, C., & on behalf of the ANIMO Study Group (2012) · Movement Disorders · doi:10.1002/mds.23872 · Cited by 129
Response to volume resuscitation in children with severe malaria*
Maitland, K., Pamba, A., Newton, C. R. J. C., & Levin, M. (2003) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000090293.32810.4e · Cited by 110
Quality of life in early Parkinson's disease: Impact of dyskinesias and motor fluctuations
Marras, C., Lang, A. E., Krahn, M. D., TOMLINSON, G. A., Naglie, G., & The Parkinson Study Group (2004) · Movement Disorders · doi:10.1002/mds.10642 · Cited by 109
Cost‐effectiveness of deep brain stimulation in patients with Parkinson's disease
Dams, J., Siebert, U., Bornschein, B., Volkmann, J., Deuschl, G., Oertel, W. H., Dodel, R. C., & Reese, J. (2013) · Movement Disorders · doi:10.1002/mds.25407 · Cited by 106
A short psychosocial questionnaire for patients with Parkinson's disease
Marinus, J., Jeukens‐Visser, M., Martı́nez-Martı́n, P., van Hilten, J. J., & Stiggelbout, A. M. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00569-3 · Cited by 106
Hippocampal volume and white matter disease in the prediction of dementia in Parkinson's disease
Kandiah, N., Zainal, N. H., Narasimhalu, K., Chander, R. J., Ng, A. Y. T., Mak, E., Au, W. L., Sitoh, Y. Y., Nadkarni, N. V., & Tan, L. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.08.024 · Cited by 105
Symptoms and Quality of Life in Late Stage Parkinson Syndromes: A Longitudinal Community Study of Predictive Factors
Higginson, I. J., Gao, W., Saleem, T., Chaudhuri, К. R., Burman, R., McCrone, P., & Leigh, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046327 · Cited by 104
Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study
Reuther, M., Spottke, E., Klotsche, J., Riedel, O., Peter, H., Berger, K., Athen, O., Köhne-Volland, R., & Dodel, R. C. (2006) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.07.009 · Cited by 100
Methylphenidate for gait impairment in Parkinson disease
Espay, A. J., Dwivedi, A. K., Payne, M., Gaines, L., Vaughan, J. E., Maddux, B. N., Slevin, J. T., Gartner, M., Sahay, A., Revilla, F. J., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182143537 · Cited by 100
Self‐rated health status in spinocerebellar ataxia—Results from a European multicenter study
Schmitz‐Hübsch, T., Coudert, M., Giunti, P., Globas, C., Balikó, L., Fancellu, R., Mariotti, C., Filla, A., Rakowicz, M. J., Charles, P., et al. (2010) · Movement Disorders · doi:10.1002/mds.22740 · Cited by 100
Low vision status and declining vision decrease Health-Related Quality of Life: Results from a nationwide 11-year follow-up study
Taipale, J., Mikhailova, A., Ojamo, M., Nättinen, J. E., Väätäinen, S. T., Gissler, M., Koskinen, S. V. P., Rissanen, H. A., Sainio, P., & Uusitalo, H. M. T. (2019) · Quality of Life Research · doi:10.1007/s11136-019-02260-3 · Cited by 92
Prospective comparative study on cost‐effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease
Valldeoriola, F., Morsi, O., TOLOSA, E. S., Rumià, J., Martı́, M. J., & Martínez‐Martín, P. (2007) · Movement Disorders · doi:10.1002/mds.21652 · Cited by 91
Eryptosis as a marker of Parkinson's disease
Pretorius, E., Swanepoel, A. C., Buys, A. V., Vermeulen, N., Duim, W., & Kell, D. B. (2014) · Aging · doi:10.18632/aging.100695 · Cited by 95
Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programme
Ueda, K., Ye, W., Lombard, L., Kuga, A., Kim, Y., Cotton, S. E., Jackson, J., & Treuer, T. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1012-1 · Cited by 89
Validity and reliability of the PDQ-39 and the PDQ-8 in English-speaking Parkinson's disease patients in Singapore
Tan, L. C. S., Luo, N., Nazri, M., Li, S. C., & Thumboo, J. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.05.007 · Cited by 90
Health-related quality of life and its determinants in Parkinson’s disease: Results of an Italian cohort study
Winter, Y., von Campenhausen, S., Arend, M., Longo, K., Boetzel, K., Eggert, K. M., Oertel, W. H., Dodel, R. C., & Barone, P. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.01.003 · Cited by 85
Preference-based quality-of-life in patients with Parkinson’s disease
Siderowf, A. D., Ravina, B. M., & Glick, H. A. (2002) · Neurology · doi:10.1212/wnl.59.1.103 · Cited by 85
Validation of the EQ-5D questionnaire in burn injured adults
Öster, C., Willebrand, M., Dyster‐Aas, J., Kildal, M., & Ekselius, L. (2009) · Burns · doi:10.1016/j.burns.2008.11.007 · Cited by 85
Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease
Odin, P., Chaudhuri, К. R., Volkmann, J., Antonini, A., Storch, A., Dietrichs, E., Pirtošek, Z., Henriksen, T., Horne, M. K., Devos, D., et al. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-018-0051-7 · Cited by 81
Physiotherapy in Parkinson’s disease: utilisation and patient satisfaction
Keus, S. H. J., Bloem, B. R., Verbaan, D., de Jonge, P. A., Hofman, M., van Hilten, B. J., & Munneke, M. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0402-7 · Cited by 79
What Effects Might Exenatide have on Non-Motor Symptoms in Parkinson’s Disease: A Post Hoc Analysis
Athauda, D. S., Maclagan, K., Budnik, N., Zampedri, L., Hibbert, S., Skene, S. S., Chowdhury, K., Avilés-Olmos, I., Limousin, P. D., & Foltynie, T. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181329 · Cited by 79
Linking clinical variables to health-related quality of life in Parkinson's disease
Chrischilles, E. A., Rubenstein, L. M., Voelker, M. D., Wallace, R. B., & Rodnitzky, R. L. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(01)00044-x · Cited by 79
Health‐related quality of life in patients with progressive supranuclear palsy
Schrag, A. E., Selai, C. E., Davis, J. C., Lees, A. J., Jahanshahi, M., & Quinn, N. P. (2003) · Movement Disorders · doi:10.1002/mds.10583 · Cited by 79
Self-citation
Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study
Kupsch, A. R., Bajaj, N. P. S., Weiland, F. L., Tartaglione, A., Klutmann, S., Buitendyk, M., Sherwin, P. F., Tate, A. C., & Grachev, I. D. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301695 · Cited by 74
Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease
Elsner, B., Kügler, J., Pohl, M., & Mehrholz, J. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010916.pub2 · Cited by 76
Association of Motor and Nonmotor Symptoms With Health-Related Quality of Life in a Large Online Cohort of People With Parkinson Disease
Bock, M. A., Brown, E. G., Zhang, L., & Tanner, C. M. (2022) · Neurology · doi:10.1212/wnl.0000000000200113 · Cited by 74
Validation of two generic patient-reported outcome measures in patients with type 2 diabetes
Matza, L. S., Boye, K. S., & Yurgin, N. (2007) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-5-47 · Cited by 74
Levodopa-Induced Dyskinesias in Parkinson’s Disease: Etiology, Impact on Quality of Life, and Treatments
Encarnacion, E. V., & Hauser, R. A. (2008) · European Neurology · doi:10.1159/000131893 · Cited by 72
Patients’ perceived health status following primary surgery for oral and oropharyngeal cancer
Rogers, S. N., Miller, R. D., Ali, K., Minhas, A., Williams, H., & Lowe, D. (2006) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2006.07.017 · Cited by 71
BeatWalk: Personalized Music-Based Gait Rehabilitation in Parkinson’s Disease
Cock, V. C. D., Dotov, D. G., Damm, L., Lacombe, S., Ihalainen, P., Picot, M., Galtier, F., Lebrun, C., Giordano, A., Driss, V., et al. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.655121 · Cited by 69
The Gilles De La Tourette Syndrome-Quality of Life Scale for Children and Adolescents (C&A-GTS-QOL): Development and Validation of the Italian Version
Cavanna, A. E., Luoni, C., Selvini, C., Blangiardo, R., Eddy, C. M., Silvestri, P. R., Calì, P. V., Seri, S., Balottin, U., Cardona, F., et al. (2013) · Behavioural Neurology · doi:10.1155/2013/140210 · Cited by 69
A Longitudinal Evaluation of Health-Related Quality of Life of Patients with Parkinson's Disease
Jeukens‐Visser, M., Verbaan, D., van Rooden, S. M., Marinus, J., van Hilten, J. J., & Stiggelbout, A. M. (2008) · Value in Health · doi:10.1111/j.1524-4733.2008.00430.x · Cited by 68
Health-Related Quality of Life in Multiple System Atrophy and Progressive Supranuclear Palsy
Winter, Y., Spottke, A. E., Stamelou, M., Cabanel, N., Eggert, K. M., Höglinger, G. U., Sixel‐Döring, F., Herting, B., Klockgether, T., Reichmann, H., et al. (2011) · Neurodegenerative Diseases · doi:10.1159/000325829 · Cited by 67
Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations
Reichmann, H., Boas, J., MacMahon, D. G., Myllylä, V. V., Hakala, A., Reinikainen, K. J., & on behalf of the ComQol Study Group (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00363.x · Cited by 67
Quality of Life in Patients with Addison's Disease:
Riedel, M., Wiese, A. B., Schürmeyer, T. H., & Brabant, G. E. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211215 · Cited by 67
Social and clinical determinants of quality of life in Parkinson’s disease in Austria: a cohort study
Winter, Y., von Campenhausen, S., Gasser, J., Seppi, K., Reese, J.-P., Pfeiffer, K. P., Bötzel, K., Oertel, W. H., Dodel, R. C., & Poewe, W. H. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5389-7 · Cited by 71
Rasagiline improves quality of life in patients with early Parkinson's disease
Biglan, K., Schwid, S., Eberly, S. W., Blindauer, K. A., Fahn, S., Goren, T., Kieburtz, K. D., Oakes, D., Plumb, S., Siderowf, A. D., et al. (2006) · Movement Disorders · doi:10.1002/mds.20764 · Cited by 66
Health‐related quality of life evaluation by proxy in Parkinson's disease: Approach using PDQ‐8 and EuroQoL‐5D
Martínez‐Martín, P., Benito‐León, J., Alonso, F., Catalán, M. J., Pondal, M., & Zamarbide, I. (2003) · Movement Disorders · doi:10.1002/mds.10656 · Cited by 65
Measuring health‐related quality of life in MSA: The MSA‐QoL
Schrag, A. E., Selai, C. E., Mathias, C. J., Low, P. A., Hobart, J. C., Brady, N., & Quinn, N. P. (2007) · Movement Disorders · doi:10.1002/mds.21649 · Cited by 64
Self-citation
Measuring quality of life in PSP
Schrag, A. E., Selai, C. E., Quinn, N. P., Lees, A. J., Litvan, I., Lang, A. E., Poon, Y., Bower, J. H., Burn, D. J., & Hobart, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000223826.84080.97 · Cited by 65
Self-citation
Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population
van der Zanden, B. P., Dijkgraaf, M. G. W., Blanken, P., de Borgie, C. A. J. M., van Ree, J. M., & van den Brink, W. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.08.012 · Cited by 63
Depression and health status in elderly hospitalized patients with chronic illness
Ünsar, S., & Süt, N. (2009) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2008.12.011 · Cited by 60
Cognitive decline in early Parkinson's disease
Kandiah, N., Narasimhalu, K., Lau, P., Seah, S., Au, W. L., & Tan, L. C. S. (2009) · Movement Disorders · doi:10.1002/mds.22384 · Cited by 59
The generic 15D instrument is valid and feasible for measuring health related quality of life in Parkinson's disease
Haapaniemi, T. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.015693 · Cited by 57
The EQ-5D (Euroqol) is a valid generic instrument for measuring quality of life in patients with dyspepsia
Mahadeva, S., Wee, H. L., Goh, K., & Thumboo, J. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-20 · Cited by 56
Is EQ-5D a valid quality of life instrument in patients with acute coronary syndrome?
Süt, H. K., & Ünsar, S. (2011) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2011.037 · Cited by 56
The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson’s disease
Shearer, J., Green, C., Counsell, C. E., & Zajicek, J. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6202-y · Cited by 55
Advanced Parkinson's disease: Clinical characteristics and treatment (part 1)
Kulisevsky, J., Luquín, M. R., Arbelo, J. M., Burguera, J. A., Carrillo, F., Castro, A., Chacón, J., Ruiz, P., Lezcano, E., Mir, P., et al. (2013) · Neurología (English Edition) · doi:10.1016/j.nrleng.2013.05.002 · Cited by 56
Enfermedad de Parkinson avanzada. Características clínicas y tratamiento (parte I)
Kulisevsky, J., Luquín, M. R., Arbelo, J. M., Burguera, J. A., Carrillo, F., Castro, A., Chacón, J., Ruiz, P., Lezcano, E., Mir, P., et al. (2013) · Neurología · doi:10.1016/j.nrl.2013.05.001 · Cited by 59
Cortical Serotonin 1A Receptor Levels Are Associated with Depression in Patients with Dementia with Lewy Bodies and Parkinson’s Disease Dementia
Sharp, S. I., Ballard, C. G., Ziabreva, I., Piggott, M. A., Perry, R. H., Perry, E. K., Aarsland, D., Ehrt, U., Larsen, J. O., & Francis, P. T. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000161058 · Cited by 55
Health-Related Quality of Life During Natalizumab Maintenance Therapy for Crohn's Disease
Feagan, B. G., Sandborn, W. J., Hass, S., Niecko, T., & White, J. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01508.x · Cited by 55
Condition-specific or generic preference-based measures in oncology? A comparison of the EORTC-8D and the EQ-5D-3L
Cancer 2015 investigators, Lorgelly, P. K., Doble, B., Rowen, D., & Brazier, J. E. (2016) · Quality of Life Research · doi:10.1007/s11136-016-1443-y · Cited by 53
Comparative assessment of migrant farm worker health in conventional and organic horticultural systems in the United Kingdom
Cross, P., Edwards, R. T., Hounsome, B., & Edwards‐Jones, G. (2007) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2007.10.048 · Cited by 57
Convergent validation of EQ-5D-5L in patients with Parkinson's disease
Alvarado‐Bolaños, A., Cervantes‐Arriaga, A., Rodríguez‐Violante, M., Llorens‐Arenas, R., Calderón‐Fajardo, H., Millán-Cepeda, R., Leal-Ortega, R., Estrada-Bellmann, I. E., & Zúñiga‐Ramírez, C. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.08.010 · Cited by 53
The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson's disease
Picillo, M., Palladino, R., Barone, P., Erro, R., Colosimo, C., Marconi, R., Morgante, F., Antonini, A., & the PRIAMO Study Group (2017) · European Journal of Neurology · doi:10.1111/ene.13290 · Cited by 51
Knee Pain and Its Severity in Elderly Koreans: Prevalence, Risk Factors and Impact on Quality of Life
Jhun, H. J., Sung, N.-J., & Kim, S. Y. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.12.1807 · Cited by 50

Authors: Schrag, A.
Affiliations: National Hospital for Neurology and Neurosurgery (GB)
Corresponding author: Schrag, A.
ORCID: Schrag, A.
Venue: Journal of Neurology, Neurosurgery & Psychiatry
Publisher: BMJ
Published: 2000-07-01
Volume: 69
Issue: 1
Pages: 67-73
ISSN: 0022-3050 (ISSN-L)
DOI: 10.1136/jnnp.69.1.67
PMC: PMC1737007
OpenAlex: W2135640360
Cited by: 327
References: 37
Citations by year: 2026: 10 · 2025: 5 · 2024: 8 · 2023: 11 · 2022: 16 · 2021: 13 · 2020: 13 · 2019: 12 · 2018: 10 · 2017: 14 · 2016: 8 · 2015: 17 · 2014: 19 · 2013: 23 · 2012: 12
FWCI: 19.84
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Topics: Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
Keywords: EQ-5D, Parkinson's disease, quality of life, assessment validity, PDQ-39, SF-36, depression, disease severity, disability, falls, postural instability, cognitive impairment, hallucinations
MeSH terms: Activities of Daily Living, Adult, Aged, Aged, 80 and over, Feasibility Studies, Female, Humans, Male, Mental Status Schedule, Middle Aged, Parkinson Disease, Quality of Life, Sick Role, Reproducibility of Results, Sickness Impact Profile

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The EQ-5D---a generic quality of life measure---is a useful instrument to measure quality of life in patients with Parkinson's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks